Welcome to 3P: pills, pearls, and patients where we will discuss current events in medicine, stories from real patient-physician encounters, and gain insight into what it's like being a physician in today's society.
Please note, that to access this episode in full instead of the teaser available just below you would need to login.
Hello again and welcome to Episode 6 of the 3P podcast, Pills, Pearls and Patients. I'm your host Dr. Marina Malak and today we're taking a Dive into Diabetes and this time for Part 2.
So if you remember in the last episode we kind of quickly went over the diagnosis of Type 2 diabetes. We focused a little bit on when to screen, as well as, some risk factors and then very quickly we talked about an algorithm management for diabetes. So we talked about the impact and importance of lifestyle including how to educate patients about diet and exercise. We also quickly went through the medications that you can use to treat patients with Type 2 diabetes. Of course we did not talk about insulin and again in this episode we will not be talking about insulin management. We reviewed that Metformin is often the first-line therapy and then there's some novel agents out like the GLP-1 agonists, as well as, the SGL2 inhibitors and their place in managing diabetes, as well as, some risks that you need to know associated with these medications and the benefits of using these medications.
Dr. Marina Malak is a family physician in Mississauga, Ontario and a lecturer and faculty member at the University of Toronto. She is actively involved in medical advocacy, and is a board member of the Mississauga Primary Care Network. She is also a member of the National Committee of Continuing Professional Development at the College of Family Physicians of Ontario, and a member of the Research Ethics Board at Trillium Health Partners.
She is passionate about patient care; medical education; and promoting mental, physical, and emotional wellness. She enjoys reading, writing, public speaking, puzzles, doodling in her bullet journal, and creating drawings on Procreate.